Nicholas J. Petrelli

41.9k total citations · 9 hit papers
301 papers, 16.6k citations indexed

About

Nicholas J. Petrelli is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nicholas J. Petrelli has authored 301 papers receiving a total of 16.6k indexed citations (citations by other indexed papers that have themselves been cited), including 189 papers in Oncology, 118 papers in Surgery and 83 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nicholas J. Petrelli's work include Colorectal Cancer Treatments and Studies (86 papers), Colorectal Cancer Surgical Treatments (77 papers) and Colorectal and Anal Carcinomas (57 papers). Nicholas J. Petrelli is often cited by papers focused on Colorectal Cancer Treatments and Studies (86 papers), Colorectal Cancer Surgical Treatments (77 papers) and Colorectal and Anal Carcinomas (57 papers). Nicholas J. Petrelli collaborates with scholars based in United States, Canada and France. Nicholas J. Petrelli's co-authors include Miguel A. Rodrı́guez-Bigas, Norman Wolmark, Greg Yothers, Michael J. O’Connell, Lemuel Herrera, Carmen J. Allegra, Linda H. Colangelo, Arnold Mittelman, Charles L. Loprinzi and Morton S. Kahlenberg and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Nicholas J. Petrelli

289 papers receiving 16.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines 2000 for Colon and Rectal Cancer Surgery

2001 966 citations Nicholas J. Petrelli et al. JNCI Journal of the National Cancer Institute profile →
A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal Cancer

2003 862 citations Nicholas J. Petrelli et al. profile →
Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.

1996 754 citations Nicholas J. Petrelli et al. Journal of Clinical Oncology profile →
Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03

2009 690 citations Linda H. Colangelo, Michael J. O’Connell et al. Journal of Clinical Oncology profile →
MicroRNA Let-7a Down-regulates MYC and Reverts MYC-Induced Growth in Burkitt Lymphoma Cells

2007 644 citations Nicholas J. Petrelli et al. profile →
The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.

1993 516 citations Norman Wolmark, Nicholas J. Petrelli et al. Journal of Clinical Oncology profile →
The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group.

1989 443 citations Nicholas J. Petrelli, H. O. Douglass et al. Journal of Clinical Oncology profile →
Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses

2011 435 citations Greg Yothers, Michael J. O’Connell et al. Journal of Clinical Oncology profile →
A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal Cancer

2014 414 citations Nicholas J. Petrelli et al. profile →

Peers

Countries citing papers authored by Nicholas J. Petrelli

Since Specialization

Citations

This map shows the geographic impact of Nicholas J. Petrelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas J. Petrelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas J. Petrelli more than expected).

Fields of papers citing papers by Nicholas J. Petrelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas J. Petrelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas J. Petrelli. The network helps show where Nicholas J. Petrelli may publish in the future.

Co-authorship network of co-authors of Nicholas J. Petrelli

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas J. Petrelli. A scholar is included among the top collaborators of Nicholas J. Petrelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas J. Petrelli. Nicholas J. Petrelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Review of Safety Data for Adenovirus 5 as a Delivery Vector for Intratumoral Cancer Gene Therapy 2023 ·Human Gene Therapy ·(unknown), Byung-Chun Yoo, (unknown), Nicholas J. Petrelli, (unknown), (unknown)	5
2	A Population Health Proposal for Increasing Breast Cancer Screening to Reduce Racial Disparities in Breast Cancer: Getting the Village Back Together 2023 ·Population Health Management ·Scott D. Siegel, (unknown), (unknown), Nora Katurakes, Heather Bittner Fagan, Matthew Hoffman, (unknown), LeRoi S. Hicks, Nicholas J. Petrelli	1
3	A cost analysis of sorafenib for desmoid tumors 2022 ·Journal of Oncology Pharmacy Practice ·Michael Johns, William T. Merritt, (unknown), (unknown), Mark G. Thompson, William M. Lee, (unknown), Nicholas J. Petrelli, (unknown)	2
4	High volume pancreaticoduodenectomy performed at an academic community cancer center 2018 ·The American Journal of Surgery ·Arvind Sabesan, (unknown), (unknown), Raafat Abdel‐Misih, Nicholas J. Petrelli, Joseph Bennett	7
5	Primary mFOLFOX6 Plus Bevacizumab Without Resection of the Primary Tumor for Patients Presenting With Surgically Unresectable Metastatic Colon Cancer and an Intact Asymptomatic Colon Cancer: Definitive Analysis of NSABP Trial C-10 2012 ·Journal of Clinical Oncology ·Laurence E. McCahill, Greg Yothers, Saima Sharif, Nicholas J. Petrelli, Lily Lai, (unknown), Jeffrey K. Giguere, Shaker R. Dakhil, Louis Fehrenbacher, Samia Lopa, Lawrence D. Wagman, Michael J. O’Connell, Norman Wolmark	111
6	Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value 2012 ·Clinical Cancer Research ·Patrick G. Gavin, Linda H. Colangelo, Debora Fumagalli, Noriko Tanaka, Matthew Y. Remillard, Greg Yothers, Chungyeul Kim, Yusuke Taniyama, Seung Il Kim, Hyun Joo Choi, Nicole L. Blackmon, Corey Lipchik, Nicholas J. Petrelli, Michael J. O’Connell, Norman Wolmark, Soonmyung Paik, Kay L. Pogue-Geile	240
7	Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses breakdown → 2011 ·Journal of Clinical Oncology ·Greg Yothers, Michael J. O’Connell, Carmen J. Allegra, J. Philip Kuebler, Linda H. Colangelo, Nicholas J. Petrelli, Norman Wolmark	435
8	Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08 2010 ·Journal of Clinical Oncology ·Carmen J. Allegra, Greg Yothers, Michael J. O’Connell, Saima Sharif, Nicholas J. Petrelli, Linda H. Colangelo, James N. Atkins, Thomas E. Seay, Louis Fehrenbacher, Richard M. Goldberg, Séamus O’Reilly, Luis Chu, Catherine A. Azar, Samia Lopa, Norman Wolmark	410
9	p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma 2000 ·Cancer ·Morton S. Kahlenberg, Daniel L. Stoler, Miguel A. Rodrı́guez-Bigas, Thomas K. Weber, Deborah L. Driscoll, Garth R. Anderson, Nicholas J. Petrelli	37
10	Familial and nutritional risk factors for p53 overexpression in colorectal cancer. 1996 ·PubMed ·Andrew N. Freedman, (unknown), James R. Marshall, Curtis Mettlin, Nicholas J. Petrelli, Jennifer D. Black, Zuo‐Feng Zhang, (unknown), (unknown)	38
11	p53 Tumor Suppressor Gene Status and the Degree of Genomic Instability in Sporadic Colorectal Cancers 1996 ·JNCI Journal of the National Cancer Institute ·Morton S. Kahlenberg, Daniel L. Stoler, Mark Basik, Nicholas J. Petrelli, (unknown), Garth R. Anderson	38
12	Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer 1994 ·Journal of Clinical Oncology ·Pascal Piedbois, Marc Buyse, G.H. Blijham, Bengt Glimelius, R. Herrmann, Frank H. Valone, Robert W. Carlson, M. Machiavelli, (unknown), Albert Abad, Nicholas J. Petrelli	162
13	CLINICAL UTILITY OF IMAGING WITH 99=TC-LABELED IMMU-4 Fab' FRAGMENT IN PATIENTS(pts) WITH CANCER OF THE COLON OR RECTUM 1994 ·Journal of Immunotherapy ·Carl Pinsky, Luz Hammershaimb, Nicholas J. Petrelli, Yehuda Z. Patt, F. Moffat, Fredrick S. Whaley	1
14	Prognostic significance of anastomotic recurrence from colorectal adenocarcinoma 1992 ·Diseases of the Colon & Rectum ·Miguel A. Rodrı́guez-Bigas, Jaroslav P. Stulc, Benjamin Davidson, Nicholas J. Petrelli	23
15	A new breast cancer marker (BCM) in monitoring disease status 1989 ·A. K. Bhargava, Nicholas J. Petrelli, Michael M. Myers, Seema A. Khan, J. Fitzpatrick, Peter Burke, (unknown), George L. Manderino	2
16	Expression of a High Molecular Weight Mucin-Type Glycoprotein in Human Colon Cancer as Defined by Monoclonal Antibody 1D ₃ ¹ 1988 ·Hybridoma ·Aniruddha Gangopadhyay, Joseph J. Barlow, Nicholas J. Petrelli, Yoshiaki Tsukada, Malaya Bhattacharya‐Chatterjee	4
17	A prospective, randomized trial of perioperative prophylactic cefamandole in elective colorectal surgery for malignancy 1988 ·Diseases of the Colon & Rectum ·Nicholas J. Petrelli, (unknown), Lemuel Herrera, Jaroslav P. Stulc, (unknown)	6
18	Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin calcium in combination with fluorouracil in patients with advanced colorectal carcinoma. 1988 ·Journal of Clinical Oncology ·Fabio Trave, Youcef M. Rustum, Nicholas J. Petrelli, L Herrera, A Mittelman, C Frank, Patrick J. Creaven	61
19	Severe and fatal toxic effects observed in treatment with high- and low-dose leucovorin plus 5-fluorouracil for colorectal carcinoma. 1987 ·PubMed ·Jean L. Grem, DeWayne Shoemaker, Nicholas J. Petrelli, H. O. Douglass	13
20	A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. 1987 ·Journal of Clinical Oncology ·Nicholas J. Petrelli, L Herrera, Youcef M. Rustum, P. J. Burke, Patrick J. Creaven, Jaroslav P. Stulc, Lawrence J. Emrich, A Mittelman	362

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact